New insider activity at Thermo Fisher ( (TMO) ) has taken place on November 14, 2025.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
In recent transactions involving Thermo Fisher stock, Sr. VP and Chief HR Officer Lisa P. Britt sold 1,057 shares, amounting to a total of $621,790. Additionally, EVP & COO Michel Lagarde sold 4,638 shares, with the sale valued at $2,756,919.
Recent Updates on TMO stock
In the last 24 hours, Thermo Fisher Scientific reported a 5% increase in Q3 revenue to $11.12 billion, surpassing consensus estimates. The company’s strategic initiatives, including new product launches, acquisitions, and a collaboration with OpenAI, have bolstered its financial performance. These developments, alongside strong growth in the pharma and biotech sectors, led to upward revisions in full-year revenue and earnings guidance. However, challenges remain in the diagnostics sector, particularly in China, and in the academic and government segments. Analysts have adjusted their price targets for Thermo Fisher, reflecting confidence in its growth strategy and innovation, despite market pressures.
Spark’s Take on TMO Stock
According to Spark, TipRanks’ AI Analyst, TMO is a Outperform.
Thermo Fisher’s strong financial performance and positive earnings call are the most significant factors driving the score. The company’s robust profitability and strategic initiatives, such as collaborations and acquisitions, support its growth outlook. However, technical indicators suggest the stock may be overbought, and the high P/E ratio indicates potential overvaluation, which tempers the overall score.
To see Spark’s full report on TMO stock, click here.
More about Thermo Fisher
YTD Price Performance: 11.82%
Average Trading Volume: 2,055,549
Technical Sentiment Signal: Buy
Current Market Cap: $220.9B